HOXA10 and polycystic ovary syndrome: Zhai et al. (2019) [57] brought therapeutic importance to the discussion, demonstrating that metformin, an insulin-sensitizing drug, enhances receptivity in PCOS animals by downregulating miR-135b, a HOXA10 repressor.